McMaster University

McMaster University

Insulin pump therapy studied at Mac

The Hamilton Spectator
Amy Kenny
May 18, 2012

For diabetics, a finger poke is like a photograph — the blood sample it takes only illustrates what’s happening in a single second. For a complete view of blood sugar levels, you’d need something more like a video stream. Fortunately, that’s exactly what a continuous glucose monitor (CGM) offers.

Because of this, McMaster Children’s Hospital will integrate CGM with insulin pumps during a one-year trial aimed at managing Type 1 diabetes in children.

“This study is taking the first step in that integration by using a pump that automatically suspends delivery of insulin when the blood sugar levels are dangerously low,” says Dr. Karen McAssey, Pediatric Endocrinologist at McMaster Children’s Hospital.

Combining the devices has given greater control to adults with Type 1 diabetes — the hope is that this study will determine the best time to start kids on similar management. According to McAssey, giving the pump the ability to respond to the CGM will create a consistent, automatic assessment/delivery system that could prevent life-threatening seizures or comas and make a difference in their daily lives.

The study, set to follow 128 patients (aged five to 18 years) at five sites across Ontario, launches Tuesday, May 22.

People interested in participating can contact study co-ordinator Tamara Caceres at 905-521-2100, ext. 76055 or email


Valid XHTML 1.0 Transitional Level Double-A conformance, W3C WAI Web Content Accessibility Guidelines 2.0